SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

Hot inflation readings and rising Treasury yields have intensified fears of tighter Fed policy, weighing on rate-sensitive small caps and pushing the Russell 2000 into correction territory. Traders are divided between expecting an oversold bounce near support and warning that the breakdown below key technical levels could extend the decline.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius is caught in a sharp AI-infrastructure and neocloud selloff, as traders weigh concerns about heavy buildout spending, financing and whether future returns will justify it; Gartners warning about consolidation in the sector has added to the concern. After a rebound, the community is split between buyers calling the decline oversold and a chance to accumulate, and skeptics who see a temporary bounce with more downside risk.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is fueling overwhelmingly bearish discussion, with traders linking the weakness to Trumps declining approval and midterm-election risk, as well as skepticism about the companys business fundamentals and Truth Social engagement. Some users argue the stock is driven more by political sentiment than operating performance, while a smaller bullish contingent sees potential for a rebound.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as crude rallies on fears that escalating Middle East conflict and attacks on tankers and energy infrastructure could disrupt oil supplies, with traders also citing tight inventories. The community is split between bulls expecting further gains and bears who see a crowded, speculation-driven war premium that could unwind if diplomacy advances or supply concerns ease.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

GMs upcoming third-quarter earnings report is the main focus, with traders weighing expectations for another strong quarter against uncertainty around costs. Discussion also centers on NHTSAs review of the L87 V8 recall remedy after reports of post-repair engine failures, and whether the issue could add warranty or legal exposure.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStops reminder that its warrants expire worthless unless exercised at the set strike is dominating discussion. With shares below that level, traders are split between expecting Ryan Cohen to extend the warrants or take action and fearing they will expire worthless; some common shareholders argue that avoiding the added shares would reduce dilution.

Kratos Defense & Security Solutions, Inc. engages in the provision of mission critical products, services and solutions for United States national security priorities. It operates through the Kratos Government Solutions (KGS) and Unmanned Systems (US) segments. The KGS segment consists of an aggregation of KGS operating segments, including microwave electronic products, space, satellite and cyber, training solutions. The US segment refers to the unmanned aerial, unmanned ground, unmanned seaborne and related command, control and communications system businesses. The company was founded on December 19, 1994, and is headquartered in Round Rock, TX.

Kratos Defense & Security Solutions Inc

KTOS is drawing attention after a prolonged selloff and repeated new lows, with traders debating whether high valuation, insider selling and analyst target cuts are outweighing its contract wins and defense-growth outlook. Some see the pullback as a buying opportunity based on demand for drones, hypersonics and other defense systems, while others remain concerned about execution, profitability and continued downward price action.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

CEO Angelos Stergious 15th-anniversary post about SELLASs next chapter with GPS and SLS009 has sparked speculation about imminent REGAL results or a possible deal, though skeptics view it as a routine anniversary message with no confirmed news. The debate centers on REGALs final analysis, which is triggered at 80 deaths; the last disclosed count was 78, and the prolonged wait is interpreted by bulls as encouraging but by others as inconclusive while the trial remains blinded.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSCIs new index eligibility rules, which could lead to Strategys removal and passive-fund selling, dominate the discussion; traders disagree over how significant the potential outflows would be, noting that exclusion is not yet confirmed. Bitcoin weakness and concerns about dilution tied to the preferred-stock buyback program add to the bearish reaction, while some traders view the selloff as a buying opportunity.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Ciphers steep selloff alongside AI and data-center peers is widely blamed on its convertible-note financing and expected dilution, compounded by concerns about managements execution and weak sector sentiment. Most discussion is frustrated and bearish over repeated lows, while some traders maintain the long-term AI infrastructure thesis and see potential for an oversold rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Companies Entering High-Stakes Market Moments

The following developments are worth watching, with Dermata Therapeutics (NASDAQ:DRMA), Verastem (NASDAQ:VSTM), NeOnc Technologies Holdings (NASDAQ:NTHI), Netcapital (NASDAQ:NCPL), Iambic Therapeutics (NASDAQ:IAM) and Estrella Immunopharma (NASDAQ:ESLA) advancing distinct strategies.

Dermatology Developer Surges 39% as Clinical Study Validates Skincare Product

Releasing positive clinical efficacy data for a newly commercialized skincare product sparked a same-session rally in a small-cap dermatology stock today, showing how investigator-graded study results can set a consumer brand apart from its competitors. Shares of Dermata Therapeutics Inc. (NASDAQ: DRMA), a San Diego skincare company, jumped Thursday after reporting positive topline results from an open-label cosmetic study evaluating its once-weekly skin renewal product, Tome Foundational Treatment, which launched commercially on August 25. In the 31-participant study, evaluated at Day 29 ...

Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving?

Dermata Therapeutics shares jumped 28.73% pre-market after reporting second-quarter results and preparing for its upcoming skincare product launch.read more...

12 Health Care Stocks Moving In Tuesday's After-Market Session

Gainers

Dermata Therapeutics (NASDAQ:DRMA) stock moved upwards by 44.4% to $1.56 during Tuesday's after-market session. The company's market cap stands at $4.5 million. As per the news, the Q2 earnings reportread more...

Dermata Therapeutics Announces A Private Placement Valued At Up To $12.4 Mln

(RTTNews) - Dermata Therapeutics Inc. (DRMA), a dermatologic firm, announced that it has entered into definitive agreements for the issuance and sale of an aggregate of 2.02 million shares of common...

Why Is Dermata Therapeutics Stock Surging Wednesday?

Dermata Therapeutics rose after announcing a private placement offering of common shares, Series C warrants, and Series D warrants.read more...

Why Did Dermata Therapeutics Stock Surge 22% Pre-Market Today?

Equity

The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal. 


Dermata Therapeutics, Inc. is a clinical-stage medical dermatology company that focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin diseases. The company was founded by David F. Hale and Gerald T. Proehl on December 8, 2014 and is headquartered in San Diego, CA.

Dermata Therapeutics Inc

Bullish Sentiment

<ul class="summary-bullets"><li>The offering, alongside two series of warrants that permit future purchases of the same amount of shares, is priced at $2.04 per unit.&nbsp;</li><li>The company plans to use the proceeds for general corporate needs, including consumer research and rollout activities for its forthcoming over‑the‑counter acne kit.</li><li>In early December, Dermata said it is preparing to launch a fresh brand identity for its over-the-counter skincare line.</li></ul>Dermata Therapeutics, Inc. (DRMA) stock surged 22% in Wednesday’s premarket after the company announced that it has struck definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal.&nbsp;The offering, alongside two series of warrants that permit future purchases of the same amount of shares, is priced at $2.04 per unit.&nbsp;<h2 class="st-heading-2">Use Of Proceeds</h2>Dermata expects roughly $4.1 million in gross proceeds initially, before fees and expenses. If all new warrants are exercised for cash, the number could rise by approximately $8.3 million, bringing total potential funding to nearly $12.4 million.&nbsp;The company plans to use the proceeds for general corporate needs, including consumer research, rollout activities for its forthcoming over‑the‑counter acne kit, licensing initiatives, possible strategic investments, and working capital.Following the announcement,&nbsp;<a href="https://stocktwits.com/symbol/DRMA">Dermata Therapeutics’ stock</a> traded over 24% higher in Wednesday’s premarket. On Stocktwits, retail sentiment around the stock jumped to ‘extremely bullish’ from ‘bearish’ territory the previous day. At the same time, message volume shifted to ‘extremely high’ from ‘extremely low’ levels in 24 hours.&nbsp;<figure class="image"><img style="aspect-ratio:934/106;" src="https://news.stocktwits-cdn.com/Screenshot_2025_12_24_084540_png_7928eb6a71.webp" alt="DRMA’s Sentiment Meter and Message Volume as of 08:30 a.m. ET on Dec. 24, 2025 | Source: Stocktwits" width="934" height="106"><figcaption>DRMA’s Sentiment Meter and Message Volume as of 08:30 a.m. ET on Dec. 24, 2025 | Source: Stocktwits</figcaption></figure>Dermata creates science-based skin treatments with a focus on over-the-counter (OTC) skin products.&nbsp;<h2 class="st-heading-2">Dermata’s&nbsp;Skincare Line</h2>In early December, the company said it is preparing to launch a fresh brand identity for its over-the-counter skincare line, signaling a move toward a science-driven, direct-to-consumer model.&nbsp;Central to the rebrand is Dermata’s proprietary Spongilla technology, which is expected to enhance the efficacy of routine skincare. By simplifying regimens and boosting results, the products are designed to amplify the overall effectiveness of a skincare routine.The latest funding strategy with a fresh financing move is aimed at extending the runway for the company’s upcoming consumer skin‑care initiatives.&nbsp;DRMA stock has declined 84% year-to-date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/intel-s-manufacturing-push-faces-fresh-test-after-nvidia-passes-on-18-a-chips-report/cLesu73REv4">Intel’s Manufacturing Push Faces Fresh Test After Nvidia Passes On 18A Chips: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

The company has entered into definitive agreements to issue roughly 2.02 million shares of its common stock in a private placement deal. 

$SPCX

$NFLX

$TSLA

$META

Which earnings release are you most looking forward to this week: $SPCX, $NFLX, $TSLA, or $META? Drop a comment for others.

Feed

News

Sentiment

Earnings

Fundamentals

Info

DRMA News